fda compounding semaglutide warning letters october 2025 Last month, the issued 25 to telehealth companies over what it called false or misleading claims about compounded GLP-1 medications. Read more at the link in the comments below Compounded GLP-1s: Why doctors worry

The fast losers are typically younger, have more weight to lose, started at higher body fat percentages, and often aren't training (meaning they're not preserving muscle, which makes the scale drop faster but the long-term outcome worse)

Genome-wide meta-analysis of 241,258 adults accounting for smoking behaviour identifies novel loci for obesity traits

They are well-regarded for their personalized approach, ensuring each patient's medication needs are addressed with precision

To ensure you heal properly, its important to follow all directions carefully

Support Your Fat Loss and Energy Goals

The review also notes that GLP-1 medicines reduce complications in conditions such as obstructive sleep apnea (OSA), expanding their cardiometabolic relevance